The purpose of HTA is to provide high-quality information to decision makers about the clinical effectiveness, cost-effectiveness, and broader impact of drugs, medical technologies, and health systems.
Yes, the Orphan Drug Regulation 141/2000 cam
The European biotech industry is calling for a robust and transparent framework in which HTA woul
From diagnosis to treatment and in terms of medicines manufactured, healthcare biotechnology is a
Some 20-30 million Europeans are affected by rare diseases.